Molecular profiling is essential in advanced colorectal cancer because certain tumor characteristics can influence systemic treatment selection. Identifying the relevant biomarker can help guide therapeutic decisions. Put your clinical knowledge to the test with this Quick Question. ##Reference## remolini C, Chalabi M, Elez E, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of Oncology. 2026;37(6):759–776.## ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no explicit or implied warranties about the information's suitability, reliability, or adequacy, including data visualization elements and graphics. We do not endorse any medical treatment, product, ideas, or service, including content from our industry partners. We do not…